Global Prostate Cancer Diagnostics Market is Expected to Grow at 20.1% in the Forecast Period of 2021 to 2028

Prostate Cancer Diagnostics Market is growing with factors such as increased research & development in prostate cancer diagnostics increase in geriatric population, launch of new products for prostate cancer diagnostics. However, Controversy related to PSA testing, high cost of diagnostics procedure may obstruct the growth of the market in the given forecast period.

Global Prostate Cancer Diagnostics Market Scenario            

According to Data Bridge Market Research, the market for prostate cancer diagnostics in Asia-Pacific region has the highest market share in prostate cancer diagnostics market. Market leader is F. Hoffmann-La Roche Ltd. and Abbott, which accounts an estimated market share of approximately 21.03% and 16.47%. The company has gained outstanding sale through providing products that are used in prostate cancer diagnostics.

In May 2020, F. Hoffmann-La Roche Ltd officially announced the acquisition of Stratos Genomics. This acquisition leads to the development of DNA-based sequencing for diagnostics use. This enhanced the healthcare diagnosis segment of the company, thus leading to more revenue generation of the company.  

Prostate Cancer Diagnostics MarketTrends Impacting the Market

Now the question is which other regions F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH and Abbott are targeting? Data Bridge Market Research has estimated a large growth in Asia-Pacific prostate cancer diagnostics market and the market leaders targeting China, Japan, among others to be their next revenue pockets for 2021.

The prostate cancer diagnostics market is becoming more competitive with companies such as F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH and Abbott as they are the top dominating companies in prostate cancer diagnostics market having maximum number of products for treatment diagnosis of prostate cancer. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global prostate cancer diagnostics market.     

For more analysis on the global prostate cancer diagnostics market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-prostate-cancer-diagnostics-market

Global Prostate Cancer Diagnostics Market Development

  • In January 2020, Siemens Healthcare GmbH and Hamilton Health Sciences officially announced a new partnership for better diagnostic and imaging services. This partnership has enhanced the product portfolio of the company and thus led to more revenue generation from the product line.

Scope of the Global Prostate Cancer Diagnostics Market

The global prostate cancer diagnostics market is segmented into 5 regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The regions are further segmented into major countries such as the UGermany, France, U.K., Italy, Spain, Russia, Switzerland, Netherlands, Belgium, Turkey, and Rest of Europe, Japan, China, Australia, South Korea, India, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, U.S., Canada, Mexico, Brazil, Argentina and Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt and Rest of Middle East and Africa. All country-based analysis of global prostate cancer diagnostics market is further analyzed based on further segmentation.

  • On the basis of product type, the prostate cancer diagnostics market is segmented into instruments, reagents & consumables and accessories. On the basis of diagnostics type, the prostate cancer diagnostics market is segmented into preliminary screening tests and confirmatory tests. On the basis of age group, the prostate cancer diagnostics market is segmented into adult, pediatric and geriatrics. On the basis of type, the prostate cancer diagnostics market is segmented into prostatic adenocarcinoma, small cell carcinoma and others. On the basis of stage, the prostate cancer diagnostics market is segmented into localized prostate cancer, recurrent/advanced prostate cancer and castration-resistant prostate cancer (metastatic and non-metastatic). On the basis of sample type, the prostate cancer diagnostics market is segmented into blood, tissue, urine and others. On the basis of end user, the prostate cancer diagnostics market is segmented into independent diagnostic laboratories, hospitals, cancer research institutes, clinics, ambulatory surgical centers and others. On the basis of distribution type, the prostate cancer diagnostics market is segmented into direct tender and retail sales.

To know more about the study https://www.databridgemarketresearch.com/reports/global-prostate-cancer-diagnostics-market

Key Pointers Covered in Global Prostate Cancer Diagnostics Market and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Siemens Healthcare GmbH
  • OPKO Health, Inc. 
  • Beckman Coulter, Inc. (A Subsidiary of Danaher)
  • Myriad Genetics, Inc.
  • Hologic, Inc.
  • Genomic Health, Inc.
  • bioMérieux, Inc.
  • Metamark Genetics, Inc.
  • MDXHEALTH
  • ACCUQUIK TEST KITS
  • DIASORIN S.P.A.
  • FUJIREBIO
  • TECO DIAGNOSTICS
  • ACON LABORATORIES, INC.
  • HUMASIS
  • EUROLYSER DIAGNOSTICA GMBH
  • PROTEOMEDIX
  • PROSTATYPEGENOMICS

Above are the key players covered in the report, to know about more and exhaustive list of prostate cancer diagnostics market companies’, contact us  https://www.databridgemarketresearch.com/toc/?dbmr=global-prostate-cancer-diagnostics-market

Research Methodology: Global Prostate Cancer Diagnostics Market 

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Chief Level Officers, Product and Marketing Manager, Distributors, Buyers.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/